KennethYeeTsaiMDPhD

Dermatopathology

Vice Chair, Research, Pathology Senior Member, Pathology and Tumor Microenvironment and Metastasis Co-Director Melanoma and Skin Cancer Center of Excellence

Join to view full profile

Dr. Tsai is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Tsai's full profile

Already have an account?

Office
12902 Magnolia Dr, SRB-3
Tampa, FL 33612
Phone+1 813-745-4864

Summary

I am a board-certified dermatologist and dermatopathologist leading a NIH funded research program focused on cutaneous squamous cell carcinoma, signaling pathways in melanoma and responses to therapy, and biomarker development for skin cancer risk and prediction of therapeutic responses. I lead a new translational research effort to address unmet needs in high-risk non-melanoma skin cancers within the Melanoma and Skin Cancer Center of Excellence.

Education & Training

Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Dermatopathology, 2007 - 2008
Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2004 - 2007
Massachusetts General HospitalInternship, Internal Medicine, 2003 - 2004
Harvard Medical SchoolClass of 2003
Massachusetts Institute of TechnologyPhD, Biology, 1996 - 2001
Yale CollegeBS, Applied Physic, 1989 - 1993

Certifications & Licensure

FL State Medical License 2016 - 2026
TX State Medical License 2008 - 2018
MA State Medical License 2007 - 2014
American Board of Dermatology Dermatology
American Board of Dermatology Dermatopathology

Awards, Honors, & Recognition

AACR Landon Foundation Cancer Prevention Award American Association for Cancer Research, 2013
Chief Resident, Dermatology 2007
Medical Scientist Training Program National Institues of Health, 2003

Publications & Presentations

PubMed

2110 citations
Genomic Classification of Cutaneous Melanoma
Rehan Akbani, Kadir C. Akdemir, B. Arman Aksoy, Monique Albert, Adrian Ally
Cell. 2015-06-18
189 citations
Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial
Nathan Fowler, R. Eric Davis, Seema Rawal, Loretta J. Nastoupil, Fredrick B. Hagemeister
The Lancet. Oncology. 2014-11-01
10 citations
Noninvasive Assessment of Epidermal Genomic Markers of UV Exposure in Skin.
Elnara Muradova, Nishit Patel, B. Sell, Bruna B. Bittencourt, Sandra S. Ojeda
The Journal of Investigative Dermatology. 2021-01-01